Evidence map›Paper›PMID 37396400›Full record

SynthesisFrontiers in neural circuits2023

Pharmacological and non-pharmacological countermeasures to Space Motion Sickness: a systematic review.

Akil Khalid, Pragnya P Prusty, Iqra Arshad, Hannah E Gustafson, Isra Jalaly, Keith Nockels, Barry L Bentley, Rahul Goel, Elisa R Ferrè

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in neural circuits, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Akil Khalid *Leicester Medical School, University of Leicester, Leicester, United Kingdom.
Pragnya P Prusty *Department of Audio-Vestibular Sciences, Institute of Health Sciences, Bhubaneswar, India.
Iqra Arshad *Department of Psychology, Royal Holloway University of London, Egham, United Kingdom.
Hannah E GustafsonDepartment of Health and Human Performance, University of Houston, Houston, TX, United States.
Isra JalalyUniversity College London Medical School, London, United Kingdom.
Keith NockelsLibrary and Learning Services, University of Leicester, Leicester, United Kingdom.
Barry L BentleyCardiff School of Technologies, Cardiff Metropolitan University, Cardiff, United Kingdom.
Rahul GoelSan Jose State University-NASA Ames Research Center, Moffett Field, CA, United States.
Elisa R FerrèDepartment of Psychological Sciences, Birkbeck University of London, London, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Space Motion Sickness (SMS) is a syndrome that affects around 70% of astronauts and includes symptoms of nausea, dizziness, fatigue, vertigo, headaches, vomiting, and cold sweating. Consequences range from discomfort to severe sensorimotor and cognitive incapacitation, which might cause potential problems for mission-critical tasks and astronauts and cosmonauts' well-being. Both pharmacological and non-pharmacological countermeasures have been proposed to mitigate SMS. However, their effectiveness has not been systematically evaluated. Here we present the first systematic review of published peer-reviewed research on the effectiveness of pharmacological and non-pharmacological countermeasures to SMS. Methods: We performed a double-blind title and abstract screening using the online Rayyan collaboration tool for systematic reviews, followed by a full-text screening. Eventually, only 23 peer-reviewed studies underwent data extraction. Results: Both pharmacological and non-pharmacological countermeasures can help mitigate SMS symptoms. Discussion: No definitive recommendation can be given regarding the superiority of any particular countermeasure approach. Importantly, there is considerable heterogeneity in the published research methods, lack of a standardized assessment approach, and small sample sizes. To allow for consistent comparisons between SMS countermeasures in the future, standardized testing protocols for spaceflight and ground-based analogs are needed. We believe that the data should be made openly available, given the uniqueness of the environment in which it is collected. Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021244131.

Indexed as

Space FlightVestibule, LabyrinthWeightlessnessHumansRandomized Controlled Trials as TopicSpace Motion Sicknessaerospace medicinehuman space flightnon-pharmacological countermeasurespharmacological countermeasuresSpace Motion Sickness (SMS)

Identifiers

PMID37396400
PMCPMC10311550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.